Pharsight

Drugs that contain Rifamycin Sodium

1. Aemcolo patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8529945 REDHILL Oral antimicrobial pharmaceutical compositions
May, 2025

(1 year, 12 days from now)

US8741948 REDHILL Oral antimicrobial pharmaceutical compositions
May, 2025

(1 year, 12 days from now)

US8263120 REDHILL Oral antimicrobial pharmaceutical compositions
May, 2025

(1 year, 12 days from now)

US8486446 REDHILL Oral antimicrobial pharmaceutical compositions
May, 2025

(1 year, 12 days from now)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Nov 16, 2023
Generating Antibiotic Incentives Now(GAIN) Nov 16, 2028

NCE-1 date: 17 November, 2027

Market Authorisation Date: 16 November, 2018

Treatment: Treatment of travelers' diarrhea caused by non-invasive strains of escherichia coli in adults

Dosage: TABLET, DELAYED RELEASE;ORAL

More Information on Dosage

AEMCOLO family patents

Family Patents